doi: 10.1111/bph.15691 176 BayarsaikhanDBayarsaikhanGLeeB
These properties positioned exendin-4 as a promising candidate for treating type 2 diabetes and, later, for addressing obesity.[117] This discovery led to the development of Byetta (exenatide), the first GLP-1 receptor agonist approved by the U.S
10.1161/JAHA.123.033654 150 WalshS.MerrickR.MilneR.BrayneC
TB-500 is the 17-amino acid LKKTET-containing fragment of thymosin beta-4, responsible for actin cytoskeleton regulation, cell migration, and anti-inflammatory signaling
When to Contact a Healthcare Provider Do not wait for a routine follow-up when a reaction is severe, rapidly worsening or feels unusual
However, the continuation into phase 3 reflects strong preliminary evidence from earlier studies and growing clinical interest in its metabolic effects